Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “In-Transit Metastasis”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)UnknownNCT05767879
What this trial is testing

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

Who this might be right for
Melanoma Stage IIIIn-Transit Metastasis of Cutaneous Melanoma
Leiden University Medical Center 28
Early research (Phase 1)Study completedNCT01469455
What this trial is testing

DNA Repair Inhibitor & Irradiation on Melanoma

Who this might be right for
Local Metastatic Melanoma
DNA Therapeutics 27
Testing effectiveness (Phase 2)Study completedNCT00471887
What this trial is testing

Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT01082887
What this trial is testing

Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)

Who this might be right for
Metastatic Melanoma
Nantes University Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00107159
What this trial is testing

Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT03685890
What this trial is testing

Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

Who this might be right for
MelanomaIn-Transit Metastasis
Vastra Gotaland Region 74
Early research (Phase 1)Ended earlyNCT05393713
What this trial is testing

Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8MelanomaMetastatic Melanoma+1 more
Mayo Clinic 3
Testing effectiveness (Phase 2)Study completedNCT00720031
What this trial is testing

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Who this might be right for
Immunotherapy
Nantes University Hospital 16
Testing effectiveness (Phase 2)UnknownNCT00116363
What this trial is testing

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Who this might be right for
Malignant MelanomaNeoplasm Metastasis
Introgen Therapeutics 25
Not applicableLooking for participantsNCT06831071
What this trial is testing

Evaluation of Hypoxia in Primary Melanoma

Who this might be right for
Melanoma
Yana Najjar 50
Testing effectiveness (Phase 2)Study completedNCT02094391
What this trial is testing

Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma

Who this might be right for
In-transit Metastases Melanoma Stage IIIB and IIIC
Gustave Roussy, Cancer Campus, Grand Paris 4
Testing effectiveness (Phase 2)WithdrawnNCT03754140
What this trial is testing

Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases

Who this might be right for
MelanomaIn-Transit Metastasis of Cutaneous Melanoma
Melanoma Institute Australia
Not applicableEnrolling By InvitationNCT06388252
What this trial is testing

Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients

Who this might be right for
Cutaneous Malignant Melanoma
Institute of Oncology Ljubljana 10
Not applicableStudy completedNCT04460053
What this trial is testing

Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion.

Who this might be right for
Malignant Melanoma
Vastra Gotaland Region 18
Not applicableLooking for participantsNCT04658303
What this trial is testing

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Who this might be right for
Melanoma
Yana Najjar 20
Early research (Phase 1)Study completedNCT00862901
What this trial is testing

Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma

Who this might be right for
Breast CancerSkin Cancer
Tufts Medical Center 48